NCT00480753View on ClinicalTrials.gov

Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 31, 2007

Study Completion Date

August 31, 2007

Conditions
Raynaud's Disease
Interventions
DRUG

Nitroglycerin

Trial Locations (1)

12206

The Center for Rheumatology, Albany

Sponsors
All Listed Sponsors
lead

MediQuest Therapeutics

INDUSTRY